Breaking AI & Tech News Analyzed

Joe Eszterhas, the swaggering pitchman of 80s and 90s Hollywood, has lived a life of excess and creativity. He wrote hits like Jagged Edge and co-scripted Flashdance, earning a then-record $3m for his Basic Instinct screenplay.Eszterhas's life story is a harrowing, rollicking immigrant's tale that whisks its hero from his birth in war-torn Hungary through the refugee camps of Allied-occupied Austria to the US rust belt. He covered the Kent State massacre as a cub reporter and interviewed Charles Manson in prison.Now 81, Eszterhas is plotting a Hollywood comeback with a rebooted Basic Instinct. He received a reported $2m from Amazon MGM studios for his script and stands to make a further $2m if and when it is filmed. The new story juggles copycat serial killers with elements of the supernatural.Eszterhas has always relished a good public scrap, and his reboot is described as anti-woke. This has sparked concerns that he may be co-opted and become a political football. However, Eszterhas insists that he is not afraid of controversy and sexuality.Despite his past struggles with drinking and drugs, Eszterhas has been clean and sober for decades. He has written a 750-page memoir, Hollywood Animal, and told his Tinseltown war stories on a recent multi-part media podcast, Ugly, Irresponsible, & Childish.

Kemiah Bob, a Texan standup comedian, has been working tirelessly to create a space for femmes of colour in comedy. In 2018, Bob launched FOC It Up, a comedy club that has grown into a platform for numerous comedians. The club has hosted mixed-bill comedy nights, a podcast, and shows at the Edinburgh fringe.Bob's latest venture, FOC Fest, is a full-day celebration of comedy, workshops, masterclasses, and networking opportunities, culminating in a comedy show at Soho Theatre in London on April 18. The event aims to provide a safe space for femmes of colour to showcase their talents and for industry professionals to network.The festival features sessions such as a standup masterclass for trans and queer people, a workshop on navigating difficult emotions through comedy, and industry panels with guests including Nana Hughes and Julia McKenzie. While the workshops are open to everyone, Bob encourages white audience members to 'check their privilege at the door'.Despite the challenges of securing funding, Bob remains committed to creating a platform for underrepresented voices in comedy. The goal is for FOC Fest to become an international institution, showcasing talent from around the world and providing support for comedians to fund their own work.FOC Fest is a testament to Bob's dedication to promoting diversity and inclusivity in the comedy industry. With its unique blend of comedy, workshops, and networking opportunities, this event is set to make a lasting impact on the comedy world.

The U.S. Supreme Court issued a decision on Monday that removes a procedural obstacle, allowing the Justice Department to proceed with a motion to dismiss the criminal case against Steve Bannon. The case stems from a 2022 conviction on two counts of contempt of Congress for refusing to comply with a subpoena issued by the House committee investigating the January 6, 2021 Capitol attack. Bannon, a former chief strategist for President Donald Trump, served a four‑month prison term after the conviction. Although the sentence is now complete, the Justice Department argues that dismissing the case is "in the interests of justice" and has asked the high court to overturn the lower‑court ruling that kept the conviction in place. Attorney Evan Corcoran, representing Bannon, welcomed the development, stating, "It has been one battle after another for five years, but today the Supreme Court vacated an unjust conviction, reaffirming that politics and prosecution don’t mix." A dismissal would expunge Bannon’s conviction from the record, but the practical impact is minimal because he has already completed his sentence. The move is part of a broader pattern of the Justice Department taking actions that benefit allies of the former president since his return to office in 2024. Background: Bannon, now 72, was a key adviser to Trump’s 2016 campaign and served as the White House’s chief strategist in 2017. After a brief fallout, he reconciled with Trump and was released from Danbury federal prison a week before Trump’s victory over Kamala Harris in the 2024 presidential election. Upon release, Bannon declared himself “far from broken” and resumed hosting his "War Room" podcast, continuing to promote the “America First” brand of right‑wing populism. Legal arguments raised by Bannon’s team centered on claims of executive privilege and challenges to the congressional committee’s authority to issue the subpoena. The case unfolds against a backdrop of numerous pardons granted by Trump to individuals convicted in connection with the Capitol riot and other allies facing charges related to attempts to overturn the 2020 election.

The Uncanny podcast has evolved from a simple Radio 4 paranormal investigations podcast to a global franchise, including live stage shows, a TV series, and a US spinoff.Host Danny Robins, known as the 'high priest of the paranormal,' has captivated audiences with spine-tingling stories, dissecting each tale with parapsychologists Evelyn Hollow and Ciarán O’Keeffe.The podcast's success can be attributed to its unique format, featuring 8 million+ downloads within two years, and its expansion into various media, including a new YouTube channel focused on classic cold cases.The Uncanny community has grown to millions, with fans bonding over shared experiences and discussing cases on social media, showcasing the power of prestige paranormal storytelling.Experts attribute the podcast's appeal to its blend of drama and true crime elements, making it a detective story that keeps listeners engaged and curious.As Uncanny continues to grow, with plans for international tours, new TV series, and conventions, its impact on popular culture and the paranormal genre is undeniable, reflecting our society's increasing fascination with the supernatural.

The Guardian’s weekly podcast roundup highlights a varied selection of new audio series, offering listeners everything from light‑hearted celebrity banter to hard‑hitting investigative journalism.Funny You Ask – In a delightfully candid moment, Mindy Kaling exclaims, “Oh, this is a quizshow?!” upon hearing Ike Barinholtz’s latest podcast, which blends trivia with rambling conversation about topics as eclectic as Chevy Chase and New Jersey Italian cuisine. The show positions itself as a breezy, low‑stakes alternative to the crowded celebrity‑interview market.Assume Nothing: What Happened to Mary Glasgow? – Host Nathan Edgar revisits the 1991 tragedy at Stradreagh mental hospital, where nursing assistant Mary Glasgow died after a patient altercation. Through interviews with Glasgow’s daughter Emma, the series treats the case as both a detective narrative and a memorial, probing whether the incident was an isolated mishap or a symptom of systemic failures.Single Ladies in Your Area – Comedians Amy Gledhill and Harriet Kemsley continue their third series, a witty exploration of 30‑something singledom. Recent guests have included Jameela Jamil and Catherine Bohart, who discuss topics ranging from “mean flirting” to the quirks of a “lesbian louche life.”The Overturn – Partnering with the Future Justice Project charity, Marnie Duke examines potential wrongful convictions, notably the case of former sub‑postmaster Robin Garbutt, imprisoned for his wife’s murder. The series asks whether the broader Post Office scandal could cast doubt on the prosecution’s narrative.Amityvilleville – Host Alex Goldman (of Hyperfixed and Reply All) teams up with Vice writer Caroline Thompson to watch all 91 films inspired by the Amityville haunting, beginning with the 1979 classic The Amityville Horror. Their commentary blends humor with genuine enthusiasm for the genre’s most bizarre entries.

Peptides are short chains of amino acids that naturally occur in the body, acting as hormones such as insulin, oxytocin and vasopressin, or as fragments released during protein digestion.In recent years, a wave of interest has turned these molecules into purported therapeutic agents for everything from weight loss to anti‑ageing and tissue repair. Prescription drugs like semaglutide (Wegovy) and tirzepatide (Mounjaro) are synthetic peptides that have undergone rigorous clinical testing and are approved for specific medical uses.However, a large portion of the market consists of unregulated, experimental peptides sold for self‑administration. These products often bypass the strict approval processes required for medicines, raising serious safety concerns.Who is using these products? Initially confined to a niche of powerlifters and bodybuilders in the 2010s, the audience has expanded dramatically. Influential figures such as podcaster Joe Rogan have promoted combinations like the “Wolverine stack” (BPC‑157 and TB‑500) for injury recovery, while other compounds—CJC‑1295, MK‑677, ipamorelin, and GHK‑Cu—are marketed for muscle growth and anti‑ageing. Social media platforms are now flooded with instructions on purchasing and injecting these substances.Scientific backing is scant. Reviews of the literature reveal that most experimental peptides have only been tested in animal or cell models. For example, BPC‑157 shows promise for tendon and muscle repair in pre‑clinical studies, but no randomized human trials have validated these effects. Similarly, TB‑4 and its synthetic analogue TB‑500 have demonstrated limited blood‑vessel formation in laboratory settings, yet human data are absent and both are listed as prohibited substances by the World Anti‑Doping Agency.Researchers also highlight a critical knowledge gap: dosage, frequency and treatment duration remain undefined, making self‑administration a gamble.Legal landscape in the UK is clear that peptides not classified as medicines fall outside the Medicines and Healthcare products Regulatory Agency’s (MHRA) remit. If a seller makes medicinal claims, the product must hold a marketing authorisation under the Human Medicines Regulations 2012. The MHRA warns that labeling items as “research use only” does not shield vendors from enforcement when evidence shows the products are intended for human consumption.Health risks are multi‑fold. Experts caution that benefits observed in animal studies do not guarantee safety in humans. Contamination with harmful impurities or bacterial endotoxins can trigger severe reactions, including septic shock. Injecting excess natural peptides may disrupt the body’s tightly regulated hormonal balance, potentially affecting multiple physiological pathways.There is also theoretical concern that augmenting peptide levels could accelerate tumour growth, as some cancers over‑express certain peptide pathways. While no direct cases have been documented, the possibility underscores the need for caution.Additional dangers include improper injection techniques (e.g., air embolism), unknown interactions with existing medications, and the lack of systematic monitoring of long‑term effects. As one researcher put it, “If something goes wrong, users may never notice until irreversible damage has occurred.”

The conflict between the United States, Israel and Iran is now spilling onto academic grounds. The Islamic Revolutionary Guard Corps (IRGC) publicly warned U.S. universities in nearby nations following weekend attacks on two Iranian campuses.According to Tehran‑based sources, at least 21 Iranian universities have sustained damage since the war erupted. The targeting of educational institutions marks a troubling escalation, raising questions about the strategic value of universities in modern warfare.In a recent podcast episode, Setareh Sadeqi, an assistant professor at the University of Tehran, discusses the motivations behind these strikes and the broader implications for Iran’s higher‑education sector. The program, produced by Al Jazeera’s AJ E Podcasts team, also explores how the “war on Iran” is extending beyond traditional battlefields into classrooms and research labs.Key takeaways include the IRGC’s threat to retaliate against U.S. institutions, the potential impact on international academic collaborations, and the symbolic message that disrupting knowledge hubs can weaken a nation’s resilience.Listeners can follow the discussion on X, Instagram, Facebook, or YouTube via @AJEPodcasts.

Palantir’s senior UK representative has warned ministers against yielding to ideologically motivated campaigners as they explore the possibility of terminating a £330 million NHS contract for the company’s Federated Data Platform (FDP).The FDP, an AI‑enabled system intended to unify patient information across the health service, is part of a broader portfolio that includes contracts with the Ministry of Defence, several police forces and the UK’s financial regulator.Louis Mosley, executive vice‑chair of Palantir UK, told The Times that abandoning the deal would jeopardise patient care and hinder progress on the NHS’s most pressing challenges. He highlighted that the platform is projected to generate £150 million in benefits by the end of the decade, delivering a £5 return for every pound spent.According to the Financial Times, senior officials have begun informal discussions about activating a break clause that would allow the FDP’s operation to be transferred to an alternative provider once the system becomes fully operational next year.Palantir, a US‑based data‑analytics firm with ties to the Israeli and US militaries and former U.S. Immigration and Customs Enforcement contracts, has faced sustained opposition from the British Medical Association, which has long criticised the use of its technology in patient‑care settings.Health officials acknowledge the reputational risk, noting that the controversy now extends beyond traditional Labour‑left and Green Party critics. A Department of Health and Social Care spokesperson emphasised that the FDP is designed to improve care coordination, accelerate cancer diagnoses and increase treatment capacity, while maintaining strict data‑security safeguards.Health Secretary Wes Streeting, speaking on the Guardian Politics Weekly podcast, recognised public unease about Palantir’s political affiliations, referencing founder Peter Thiel’s right‑wing connections. He reassured listeners that Palantir does not have direct access to patient data, stating, "The platform is operated by us; Palantir never sees the data."Adoption of Palantir’s technology within the NHS has risen from 118 to 151 organisations since June, though it remains short of the government’s target of 240 organisations by year‑end. Labour backbencher Clive Lewis noted that the issue is becoming a visible concern for voters, reflecting broader anxieties about AI and foreign‑owned infrastructure in critical public services.

As gas prices surge past $4 a gallon, Donald Trump's approval rating has plummeted to 33%, the lowest during his second term, according to a University of Massachusetts Amherst poll. The war on Iran, which has led to rising fuel costs, is becoming a liability for the Republican party.JD Vance, the vice-president and potential 2028 Republican presidential candidate, is attempting to distance himself from the Iran conflict. Sources close to Vance are speaking out, claiming he has always been against the war. Axios reported that Vance had expressed skepticism about Israel's prime minister, Benjamin Netanyahu, over the war.Vance's wife, Usha, is also gearing up for a public role, launching a podcast called 'Storytime With the Second Lady' aimed at children, a move seen as an attempt to build a positive public image ahead of the 2028 election.Despite these efforts, Vance's charisma and credibility are being questioned. His appearance on The Benny Show podcast, where he discussed UFOs and aliens as 'demons,' has raised concerns about his judgment and appeal to a broader audience.